The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Regulatory News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.50
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 1.00 (5.714%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 18.00
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Slimbiome in Nutri-bites

8 Mar 2018 07:00

RNS Number : 9874G
OptiBiotix Health PLC
08 March 2018
 

OptiBiotix Health plc

("OptiBiotix" or the "Company")

 Launch of Slimbiome® in Nutri-bites®

 

OptiBiotix Health plc (AIM:OPTI), a life sciences business developing compounds to tackle obesity, and high cholesterol, announces the launch of its award winning SlimBiome® in Nutri-Bites® with its US partner, Cereal Ingredients ("CII"), at the 2018 Natural Products Expo West & Engredea. The exhibition is the world's largest trade show for organic, natural and healthy products and typically attract more than 80,000 food and ingredient buyers from around the world. OptiBiotix will join CII at stand 3788.

 

OptiBiotix has partnered with specialty ingredients manufacturer CII Ingredients, to launch its patented weight management technology, SlimBiome® in CII's Nutri-Bites® range of cereal based food products. This extends SlimBiome® applications from snack bars and shakes to breakfast cereals and bakery products (e.g. cookies, cakes and tortillas) as well as increasing the range of options for healthy snacks, yoghurts and cereal bars.

 

Products in the Nutri-Bites® range contain expanded cereal pieces and are formulated with a choice of protein sizes and content. These can be applied to granola and snack mix inclusions, nutritional and cereal bars and coated snacks, or just used as a healthy crunch topping.

 

This is a continuation of OptiBiotix's focus on the US market following last years supply & manufacturing Aareement with CII, announced on 12 December 2017. SlimBiome® is the first in a range of products which helps to improve human health through the science of the microbiome. Other products under development in the range include ImmunoBiome, ® CardioBiome® and WellBiome®.

 

Cereal Ingredients is a privately held speciality ingredients manufacturer based in Kansas, USA, dedicated to the development, manufacture and supply of unique, high-quality food ingredients which contribute a meaningful point of difference.

 

Christina Wood, OptiBiotix Sales and Marketing Director, said: "Many cereals and snack bars on the market are deceptively high in sugar and calories, leading consumers with healthy intentions who use these products to gain, rather than lose, weight. By combining OptiBiotix's award winning SlimBiome® technology with CII's market-leading ingredients manufacturing capacity and product development, we have created a delicious functional solution which can help customers manage their weight by reducing snacking and food intake without food cravings. We are delighted to share this innovative science based approach to weight management with food and ingredient buyers from around the world at the Natural Products Expo West & Engredea show."

 

For more information about Optibiotix, please visit www.optibiotix.com

 

 

 

For further information, please contact:

 

OptiBiotix Health plc

www.optibiotix.com

Stephen O'Hara, Chief Executive

Contact via Walbrook below

Walbrook PR Ltd

Tel: 020 7933 8780 or optibiotix@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

 

About OptiBiotix - www.optibiotix.com

OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease.

 

The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes.

 

OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreen® and OptiBiotic® platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUBSARWSAORAR
Date   Source Headline
18th Nov 20207:00 amRNSLicense and supply agreement with Genuine Health
12th Oct 20207:00 amRNSLaunch of weight management products
9th Oct 20202:00 pmRNSInvestor presentation
8th Oct 20207:00 amRNSHead of Quality & Operations appointment
6th Oct 20207:00 amRNSExclusive distribution agreement
5th Oct 202011:05 amRNSSecond Price Monitoring Extn
5th Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSFDA Investigational New Drug authorisation
28th Sep 20207:00 amRNSExclusive distribution agreement
24th Sep 20207:00 amRNSHalf-year Report
22nd Sep 20207:00 amRNSLicense agreement for SlimBiome® Medical in the US
17th Sep 20207:00 amRNSDistributor agreement with Ayalla Marketing
15th Sep 202011:06 amRNSSecond Price Monitoring Extn
15th Sep 202011:00 amRNSPrice Monitoring Extension
15th Sep 20207:00 amRNSSweetBiotix sweet fibres agreement
3rd Sep 20202:05 pmRNSSecond Price Monitoring Extn
3rd Sep 20202:00 pmRNSPrice Monitoring Extension
3rd Sep 202011:05 amRNSSecond Price Monitoring Extn
3rd Sep 202011:00 amRNSPrice Monitoring Extension
11th Aug 20207:00 amRNSScientific and commercial development update
5th Aug 20207:00 amRNSExtension of terms for OptiBiome with OptiPharm
30th Jul 20207:00 amRNSExtension of terms for WellBiome with Maxum Foods
23rd Jul 20207:00 amRNSExtension of terms for WellBiome with Agropur
20th Jul 20207:00 amRNSTrading and commercial update
16th Jul 20207:00 amRNSExtension of terms, territories and products
14th Jul 20207:00 amRNSExtension of terms for WellBiome
9th Jul 202011:29 amRNSResult of AGM
6th Jul 20207:00 amRNSExtension of terms for WellBiome
1st Jul 20207:00 amRNSDistribution agreement with Actial Farmaceutica
29th Jun 20207:00 amRNSLaunch of WellBiome
17th Jun 20207:00 amRNSNotice of AGM
3rd Jun 20207:00 amRNSExercise of Warrant
2nd Jun 20203:35 pmRNSGrant of Options
1st Jun 20203:45 pmRNSHolding(s) in Company
1st Jun 20207:00 amRNSCambridge Commodities appointment as distributor
28th May 20207:00 amRNSFinal Results
20th May 20207:00 amRNSLaunch of SlimBiome gummies in USA
18th May 20207:00 amRNSTrading and commercial update
11th May 20207:00 amRNSExclusive distribution agreement with MAXCARE Inc
5th May 20207:00 amRNSDistribution of products in China and Hong Kong
4th May 20207:00 amRNSNon-exclusive agreement with Smart For Life
17th Apr 20204:24 pmRNSHolding(s) in Company
17th Apr 202011:03 amRNSPlacing and Related Party Transaction
6th Apr 20207:00 amRNSSlimBiome® contract manufacturing agreement
2nd Apr 20207:00 amRNSSlimBiome® contract manufacturing agreement
31st Mar 20207:00 amRNSExclusive licence agreement for OptiBiome®
24th Mar 20207:00 amRNSExtension of territories for GoFigure®
23rd Mar 20207:00 amRNSChange of accounting year end
19th Mar 20204:42 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.